サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1671178

皮膚科治療薬の世界市場：市場規模・シェア・動向、業界分析 (治療別・種類別・投与経路別・流通チャネル別・薬剤クラス別・地域別)、将来予測 (2025年～2034年)

Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy, Type, Route of Administration, Distribution Channel, Drug Class, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 119 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
皮膚科治療薬の世界市場：市場規模・シェア・動向、業界分析 (治療別・種類別・投与経路別・流通チャネル別・薬剤クラス別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年02月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、皮膚科治療薬の市場規模は2034年までに661億5,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

皮膚科治療薬市場の成長は、にきび、乾癬、湿疹、皮膚がんなどの皮膚疾患の有病率の増加と治療オプションの進歩が大きな原動力となっています。主な促進要因としては、特に慢性かつ重度の皮膚疾患に対する生物製剤や標的治療薬に対する需要の高まりや、皮膚の健康に対する意識の高まりが挙げられます。皮膚科治療薬の市場機会は、一般用医薬品（OTC）の拡大や、遺伝子検査を活用した個別化皮膚科治療へのシフトの高まりに存在します。

美容皮膚科治療の増加、外用薬処方の革新、患者エンゲージメント向上のためのデジタルヘルスソリューションの統合などの動向が市場を形成しています。このような先進治療の採用が進み、新興市場における医療へのアクセスが増加していることから、皮膚科治療薬市場は継続的な成長が見込まれています。

皮膚科治療薬市場：分析概要

治療別では、にきび治療分野が皮膚科治療薬市場の売上高で最大のシェアを占めています。これは、特に10代や若年成人の間でにきびの有病率が高く、外用薬や経口治療薬が広く使用されているためです。乾癬もまた重要なセグメントであり、生物学的製剤や標的治療の採用が力強い成長を牽引しています。

乾癬や湿疹などの慢性皮膚疾患には専門的な治療が必要であるため、種類別では処方薬が皮膚科治療薬の市場シェアを独占しています。一般用医薬品（OTC）分野は、利用しやすく費用対効果の高いセルフケアを好む消費者の増加により、急速に成長しています。

投与経路別では、多くの皮膚疾患の第一選択治療である外用剤が最大のシェアを占めています。経口剤セグメントは、特に新しい経口生物製剤のイントロダクションや、にきびや乾癬などの症状に対する全身治療により、最も高い成長を記録しています。

流通チャネル別では、病院薬局部門が最大の市場シェアを占めていますが、これは主に重度の皮膚疾患に対する専門的治療の需要によるものです。小売薬局部門は、OTC皮膚科製品に対する需要の高まりと、これらの治療に対する消費者のアクセスの拡大により、最も急成長している部門です。

北米は、先進医療システム、高い皮膚科認知度、製薬会社の強力な市場プレゼンスにより、皮膚科治療薬の世界市場シェアを独占しています。アジア太平洋は、医療へのアクセスの増加、認知度の向上、皮膚科治療に対する需要の高まりを背景に、最も急速に成長している地域です。

皮膚科治療薬市場の主要企業は、アッヴィ、イーライリリー・アンド・カンパニー、ジョンソン・エンド・ジョンソン、ノバルティス、グラクソ・スミスクライン、アムジェン、ファイザー、サノフィ、バイエル、メルク・アンド・カンパニー、UCB、ブリストル・マイヤーズスクイブ、ロレアル、ガルデルマ、メダ・ファーマシューティカルズなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の皮膚科治療薬市場の洞察

  • 市場スナップショット
  • 皮膚科治療薬の市場力学
    • 促進要因と機会
      • 皮膚科における生物学的製剤の需要増加
      • 外用治療薬と市販薬（OTC）への移行
    • 抑制要因と課題
      • 皮膚科治療薬の高額な費用
  • PESTLE分析
  • 皮膚科治療薬市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の皮膚科治療薬市場：治療別

  • 主な分析結果
  • イントロダクション
  • ニキビ
  • 乾癬
  • 酒さ様皮膚炎
  • 脱毛症
  • その他

第6章 世界の皮膚科治療薬市場：種類別

  • 主な分析結果
  • 処方箋
  • 店頭販売（OTC）

第7章 世界の皮膚科治療薬市場：投与経路別

  • 主な分析結果
  • イントロダクション
  • 局所
  • 経口
  • 非経口

第8章 世界の皮膚科治療薬市場：流通チャネル別

  • 主な分析結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • その他

第9章 世界の皮膚科治療薬市場：薬剤クラス別

  • 主な分析結果
  • イントロダクション
  • 抗感染薬
  • コルチコステロイド
  • ニキビ予防
  • カルシニューリン阻害剤
  • レチノイド
  • その他

第10章 世界の皮膚科治療薬市場：地域別

  • 主な分析結果
  • イントロダクション
    • 皮膚科治療薬市場の評価：地域別 (2020～2034年)
  • 北米
    • 北米：治療別 (2020～2034年)
    • 北米：種類別 (2020～2034年)
    • 北米：投与経路別 (2020～2034年)
    • 北米：流通チャネル別 (2020～2034年)
    • 北米：薬剤クラス別 (2020～2034年)
    • 米国
    • カナダ
  • 欧州
    • 欧州：治療別 (2020～2034年)
    • 欧州：種類別 (2020～2034年)
    • 欧州：投与経路別 (2020～2034年)
    • 欧州：流通チャネル別 (2020～2034年)
    • 欧州：薬剤クラス別 (2020～2034年)
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：治療別 (2020～2034年)
    • アジア太平洋：種類別 (2020～2034年)
    • アジア太平洋：投与経路別 (2020～2034年)
    • アジア太平洋：流通チャネル別 (2020～2034年)
    • アジア太平洋：薬剤クラス別 (2020～2034年)
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：治療別 (2020～2034年)
    • 中東・アフリカ：種類別 (2020～2034年)
    • 中東・アフリカ：投与経路別 (2020～2034年)
    • 中東・アフリカ：流通チャネル別 (2020～2034年)
    • 中東・アフリカ：薬剤クラス別 (2020～2034年)
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：治療別 (2020～2034年)
    • ラテンアメリカ：種類別 (2020～2034年)
    • ラテンアメリカ：投与経路別 (2020～2034年)
    • ラテンアメリカ：流通チャネル別 (2020～2034年)
    • ラテンアメリカ：薬剤クラス別 (2020～2034年)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第11章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第12章 企業プロファイル

  • AbbVie
  • Amgen
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Galderma
  • GlaxoSmithKline
  • Johnson & Johnson
  • L'Oreal
  • Meda Pharmaceuticals
図表

List of Tables:

  • Table 1 Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 2 Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 3 Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 6 North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 7 North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 11 U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 13 U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 16 Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 17 Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 19 Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 20 Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 21 Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 22 Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 26 UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 28 UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 29 UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 30 UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 31 France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 32 France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 33 France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 35 France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 36 Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 37 Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 39 Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 41 Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 43 Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 46 Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 47 Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 49 Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 50 Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 56 Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 59 Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 60 Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 71 China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 73 China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 75 China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 76 India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 77 India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 78 India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 79 India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 80 India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 86 Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 88 Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 89 Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 90 Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 96 South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 97 South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 98 South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 99 South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 100 South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 101 Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 102 Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 103 Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 105 Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 121 UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 122 UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 123 UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 125 UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 126 Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 127 Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 128 Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 129 Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 130 Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 131 South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 132 South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 134 South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 135 South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 141 Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 142 Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 143 Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 144 Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 145 Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 146 Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 147 Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 148 Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 149 Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 150 Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 151 Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 152 Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 153 Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 154 Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 155 Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 156 Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 157 Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 158 Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 159 Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 160 Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Dermatology Drugs Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapy
  • Figure 7. Global Dermatology Drugs Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Dermatology Drugs Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global Dermatology Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Dermatology Drugs Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Drug Class
  • Figure 15. Global Dermatology Drugs Market, by Drug Class, 2024 & 2034 (USD Billion)
目次
Product Code: PM1106

The dermatology drugs market size is expected to reach USD 66.15 billion by 2034, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Size, Share, Trends, Industry Analysis Report: By Therapy (Acne, Psoriasis, Rosacea, Alopecia, and Others), Type, Route of Administration, Distribution Channel, Drug Class, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dermatology drugs market growth is significantly driven by an increasing prevalence of skin conditions, such as acne, psoriasis, eczema, and skin cancer, coupled with advancements in treatment options. Key drivers include the rising demand for biologics and targeted therapies, particularly for chronic and severe skin diseases, as well as the growing awareness about skin health. Dermatology drugs market opportunities exist in the expansion of over-the-counter (OTC) products and the increasing shift toward personalized dermatology treatments, leveraging genetic testing for more tailored care.

Trends such as the rise in aesthetic dermatology treatments, innovations in topical drug formulations, and the integration of digital health solutions for improved patient engagement are shaping the market. With the growing adoption of these advanced treatments and increasing healthcare access in emerging markets, the dermatology drugs market is poised for continued growth.

Dermatology Drugs Market Report Highlights:

Based on therapy, the acne therapy segment holds the largest share of the dermatology drugs market revenue due to the high prevalence of acne, especially among teens and young adults, and the widespread use of topical and oral treatments. Psoriasis is also a significant segment, with strong growth driven by the adoption of biologics and targeted therapies.

The prescription drugs segment, by type, dominates the dermatology drugs market share due to the need for specialized treatments for chronic skin conditions, such as psoriasis and eczema. The over-the-counter (OTC) segment is growing rapidly, driven by increasing consumer preference for accessible, cost-effective self-care solutions.

In terms of route of administration, the topical segment holds the largest share, as it is the first-line treatment for many skin conditions. The oral segment is registering the highest growth, especially with the introduction of new oral biologics and systemic treatments for conditions such as acne and psoriasis.

The hospital pharmacies segment, by distribution channel, holds the largest market share, primarily due to the demand for specialized treatments for severe dermatological conditions. The retail pharmacies segment is the fastest-growing segment, driven by the increasing demand for OTC dermatology products and greater consumer access to these treatments.

North America dominates the global dermatology drugs market share due to advanced healthcare systems, high dermatology awareness, and strong market presence of pharmaceutical companies. Asia Pacific is the fastest-growing region, driven by increasing healthcare access, rising awareness, and growing demand for dermatology treatments.

A few key players in the dermatology drugs market are AbbVie, Eli Lilly and Company, Johnson & Johnson, Novartis, GlaxoSmithKline, Amgen, Pfizer, Sanofi, Bayer, Merck & Co., UCB, Bristol-Myers Squibb, L'Oreal, Galderma, and Meda Pharmaceuticals.

Polaris Market Research has segmented the dermatology drugs market report on the basis of therapy, type, route of administration, distribution channel, drug class, and region:

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

  • Acne
  • Psoriasis
  • Rosacea
  • Alopecia
  • Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

  • Prescription
  • Over-the-Counter (OTC)

By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)

  • Topical
  • Oral
  • Parenteral

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

  • Anti-Infectives
  • Corticosteroids
  • Anti-Acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermatology Drugs Market Insights

  • 4.1. Dermatology Drugs Market - Frequency Snapshot
  • 4.2. Dermatology Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Demand for Biologics in Dermatology
      • 4.2.1.2. Shift Toward Topical Treatments and Over-the-Counter (OTC) Products
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Dermatology Drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dermatology Drugs Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dermatology Drugs Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
  • 5.3. Acne
    • 5.3.1. Global Dermatology Drugs Market, Acne, by Region, 2020-2034 (USD Billion)
  • 5.4. Psoriasis
    • 5.4.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2020-2034 (USD Billion)
  • 5.5. Rosacea
    • 5.5.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2020-2034 (USD Billion)
  • 5.6. Alopecia
    • 5.6.1. Global Dermatology Drugs Market, by Alopecia, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dermatology Drugs Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
  • 6.3. Prescription
    • 6.3.1. Global Dermatology Drugs Market, by Prescription, by Region, 2020-2034 (USD Billion)
  • 6.4. Over-the-Counter (OTC)
    • 6.4.1. Global Dermatology Drugs Market, by Over-the-Counter (OTC), by Region, 2020-2034 (USD Billion)

7. Global Dermatology Drugs Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Topical
    • 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Global Dermatology Drugs Market, Oral, by Region, 2020-2034 (USD Billion)
  • 7.5. Parenteral
    • 7.5.1. Global Dermatology Drugs Market, Parenteral, by Region, 2020-2034 (USD Billion)

8. Global Dermatology Drugs Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Dermatology Drugs Market, by Drug Class

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 9.3. Anti-Infectives
    • 9.3.1. Global Dermatology Drugs Market, by Anti-Infectives, by Region, 2020-2034 (USD Billion)
  • 9.4. Corticosteroids
    • 9.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2020-2034 (USD Billion)
  • 9.5. Anti-Acne
    • 9.5.1. Global Dermatology Drugs Market, by Anti-Acne, by Region, 2020-2034 (USD Billion)
  • 9.6. Calcineurin Inhibitors
    • 9.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2020-2034 (USD Billion)
  • 9.7. Retinoids
    • 9.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2020-2034 (USD Billion)
  • 9.8. Others
    • 9.8.1. Global Dermatology Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Dermatology Drugs Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Dermatology Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Dermatology Drugs Market - North America
    • 10.3.1. North America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.3.2. North America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.3.3. North America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.3.4. North America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.3.5. North America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.7. Dermatology Drugs Market - U.S.
      • 10.3.7.1. U.S.: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.7.2. U.S.: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.3. U.S.: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.7.4. U.S.: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.7.5. U.S.: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.3.8. Dermatology Drugs Market - Canada
      • 10.3.8.1. Canada: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.3.8.2. Canada: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.3.8.3. Canada: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.3.8.4. Canada: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.3.8.5. Canada: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.4. Dermatology Drugs Market - Europe
    • 10.4.1. Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.6. Dermatology Drugs Market - UK
      • 10.4.6.1. UK: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.7. Dermatology Drugs Market - France
      • 10.4.7.1. France: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.8. Dermatology Drugs Market - Germany
      • 10.4.8.1. Germany: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.9. Dermatology Drugs Market - Italy
      • 10.4.9.1. Italy: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.10. Dermatology Drugs Market - Spain
      • 10.4.10.1. Spain: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.11. Dermatology Drugs Market - Netherlands
      • 10.4.11.1. Netherlands: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.12. Dermatology Drugs Market - Russia
      • 10.4.12.1. Russia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.4.13. Dermatology Drugs Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.5. Dermatology Drugs Market - Asia Pacific
    • 10.5.1. Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.6. Dermatology Drugs Market - China
      • 10.5.6.1. China: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.7. Dermatology Drugs Market - India
      • 10.5.7.1. India: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.8. Dermatology Drugs Market - Malaysia
      • 10.5.8.1. Malaysia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.9. Dermatology Drugs Market - Japan
      • 10.5.9.1. Japan: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.10. Dermatology Drugs Market - Indonesia
      • 10.5.10.1. Indonesia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.11. Dermatology Drugs Market - South Korea
      • 10.5.11.1. South Korea: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.12. Dermatology Drugs Market - Australia
      • 10.5.12.1. Australia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.5.13. Dermatology Drugs Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.6. Dermatology Drugs Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.6. Dermatology Drugs Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.7. Dermatology Drugs Market - UAE
      • 10.6.7.1. UAE: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.8. Dermatology Drugs Market - Israel
      • 10.6.8.1. Israel: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.9. Dermatology Drugs Market - South Africa
      • 10.6.9.1. South Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.6.10. Dermatology Drugs Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
  • 10.7. Dermatology Drugs Market - Latin America
    • 10.7.1. Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.6. Dermatology Drugs Market - Mexico
      • 10.7.6.1. Mexico: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.7. Dermatology Drugs Market - Brazil
      • 10.7.7.1. Brazil: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.8. Dermatology Drugs Market - Argentina
      • 10.7.8.1. Argentina: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)
    • 10.7.9. Dermatology Drugs Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Dermatology Drugs Market, by Therapy, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Dermatology Drugs Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Dermatology Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Dermatology Drugs Market, by Distribution Channel, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Dermatology Drugs Market, by Drug Class, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AbbVie
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Amgen
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bayer
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bristol-Myers Squibb
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Eli Lilly and Company
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Galderma
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GlaxoSmithKline
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Johnson & Johnson
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. L'Oreal
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Meda Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development